Page last updated: 2024-09-03

ru-28362 and n-methyl-3,4-methylenedioxyamphetamine

ru-28362 has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 1 studies

Compound Research Comparison

Studies
(ru-28362)
Trials
(ru-28362)
Recent Studies (post-2010)
(ru-28362)
Studies
(n-methyl-3,4-methylenedioxyamphetamine)
Trials
(n-methyl-3,4-methylenedioxyamphetamine)
Recent Studies (post-2010) (n-methyl-3,4-methylenedioxyamphetamine)
175034,2762111,392

Protein Interaction Comparison

ProteinTaxonomyru-28362 (IC50)n-methyl-3,4-methylenedioxyamphetamine (IC50)
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.9351
Sodium-dependent serotonin transporterHomo sapiens (human)1.1761
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)1.06
Sodium-dependent dopamine transporter Homo sapiens (human)1.7609

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lowy, MT; Meltzer, HY; Nash, JF1

Other Studies

1 other study(ies) available for ru-28362 and n-methyl-3,4-methylenedioxyamphetamine

ArticleYear
Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
    European journal of pharmacology, 1989, Apr-12, Volume: 163, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Androstanols; Animals; Corpus Striatum; Corticosterone; Hydroxyindoleacetic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Serotonin

1989